Diabytes
USFDA completes inspection of Cadila's Changodar plant
Drug firm Cadila Healthcare today said the USFDA has completed inspection of its manufacturing plant at Changodar with "no observation".
Trending Photos
7- 7
- 7
- 10
)
New Delhi: Drug firm Cadila Healthcare today said the USFDA has completed inspection of its manufacturing plant at Changodar with "no observation".
The United States Food and Drug Administration (USFDA) inspected the company's topical manufacturing facility at Changodar from April 3-7, 2017, Cadila Healthcare said in a BSE filing.
"At the end of the inspection, no observation (483) is issued," it added.
The company has filed 17 products with the FDA from this facility, Cadila Healthcare said.
Cadila Healthcare stock today closed 1.51 percent up at Rs 454.85 per scrip on BSE.
Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.
Live Tv
 "DNA: Indian Navy Successfully Tests Long-Range Missile")
 "DNA: Government’s Shocking Statement on Indian Railways' Blankets")
 "DNA: Shocking ‘Vote Jihad’ Allegation Surfaces in Delhi")
 "DNA: Eknath Shinde Steps Back, BJP to Decide CM")
 "DNA: Where Is Bushra Bibi Amidst Pakistan’s Chaos?")
 "DNA: Chhattisgarh Couple Promotes Helmet Safety at Wedding, Video Goes Viral")
 "DNA: IIT Kanpur Develops ‘Invisible’ Shield for Indian Army!")
 "DNA: AIMPLB's 'provocative plan' on Waqf leaked!")
 "DNA: Sambhal riots- shocking revelations in police FIR")
 "DNA: Violence Erupts in Bangladesh After ISKCON Monk Chinmoy Das’ Arrest")
